Arlene Morris - 26 Jun 2024 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
Director
Signature
/s/ Jennifer Tousignant, Attorney-in-Fact for Arlene Morris
Issuer symbol
VRDN
Transactions as of
26 Jun 2024
Transactions value $
$0
Form type
4
Filing time
28 Jun 2024, 16:05:08 UTC
Previous filing
12 Jun 2024
Next filing
16 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRDN Stock Option (Right to Buy) Award $0 +21,000 $0 21,000 26 Jun 2024 Common Stock 21,000 $12.31 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full upon the earlier to occur of (i) June 26, 2025 or (ii) the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service on the Board.

Remarks:

Exhibit 24 - Power of Attorney